Re-Opening the Critical Window for Estrogen Therapy

Area of Science:

• Neuroscience
• Endocrinology
• Molecular Biology

Background:

• Estradiol (E2) offers cognitive benefits, but its therapeutic effects diminish with age, indicating a closed critical window.
• The mechanism behind this age-related loss of E2's cognitive benefits remains unclear.
• Estrogen receptors, ERα and ERβ, mediate E2's actions in the brain.

Purpose of the Study:

• To investigate if upregulating hippocampal estrogen receptor alpha (ERα) or estrogen receptor beta (ERβ) can restore the therapeutic potential of E2.
• To determine if ERα or ERβ upregulation can rejuvenate E2-induced hippocampal plasticity and cognitive function in aged female rats.
• To elucidate the role of ERα and ERβ in regulating the critical window for E2's cognitive benefits.

Main Methods:

• Ovariectomized female rats (15 months old) received adeno-associated viral vectors to express ERα, ERβ, or GFP in the hippocampus.
• Following gene therapy, animals were treated with 17β-estradiol-3-benzoate (EB) or oil vehicle for 5 weeks.
• Spatial memory and NMDAR-mediated synaptic transmission were assessed to evaluate cognitive function and plasticity.

Main Results:

• Estradiol treatment failed to improve spatial memory in rats expressing green fluorescent protein (GFP) or ERβ, confirming a closed critical window.
• Enhancing ERα expression, followed by estradiol treatment, significantly improved spatial memory compared to control groups.
• ERα upregulation also led to enhanced NMDAR-mediated synaptic transmission, indicating restored hippocampal plasticity.

Conclusions:

• The critical window for estradiol's cognitive and hippocampal benefits can be reinstated by increasing ERα expression.
• ERα activity is crucial for regulating synaptic plasticity mechanisms underlying memory.
• Targeting ERα may offer a therapeutic strategy to overcome age-related cognitive decline and restore E2 responsiveness.